Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
A Phase II Trial of Twice Daily Oral Topotecan as a Radiation Sensitizer with Twice Daily Radiotherapy for Newly Diagnosed Small Cell Lung Cancer
Arnold, Susanne
(PI)
Internal Medicine
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
12/11/02
→
11/30/05
Funding
GlaxoSmithKline:
$34,679.00
View all
View less